Waseem Ansari, MD
Ophthalmology · Saint Louis, MONPI 1629496849
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Eyepoint US, Inc. at 33.2% of the total. Reporting peaked in 2024 at $4,814 and has fallen 82.0% since, to $865 in 2025.
Across 107 payments — averaging $82.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eyepoint US, Inc.$3K
- Alimera Sciences, Inc.$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$963
- Regeneron$513
- AbbVie$513
- Apellis Pharmaceuticals, Inc.$466
- plus $2K from 8 others
What the payments were for
- Speaking & faculty fees$1,39016%
- Travel & lodging$2,89133%
- Food & beverage$4,54251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eyepoint US, Inc. | 7 | $2,933 |
| Alimera Sciences, Inc. | 10 | $1,660 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 17 | $963 |
| Regeneron | 3 | $513 |
| AbbVie(2 entities) | 19 | $513 |
| Apellis Pharmaceuticals, Inc. | 8 | $466 |
| Regeneron Healthcare Solutions, Inc. | 13 | $395 |
| Harrow Eye, LLC | 10 | $352 |
| Novartis | 4 | $351 |
| Genentech USA, Inc. | 8 | $251 |
| Astellas Pharma US Inc | 5 | $195 |
| Amgen | 1 | $125 |
| Bausch & Lomb Americas Inc. | 1 | $89 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYP-1901$2,704
- YUTIQ$1,745
- Iluvien$1,515
- STELLARIS PC$563
- LIGHT PIPES$563
- OPHTHALMIC INSTRUMENTS$563
- VITESSE$563
- Syfovre$383
- IHEEZO$125
- TRIESENCE$125
- TEPEZZA$125
- VABYSMO$122
- OZURDEX$109
- EYLEA HD$103
How this compares
$8,823 in reported general payments places this provider in the 85th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 125 | $6,891 |
| Ketorolac Tromethamine | 42 | $1,869 |
| Difluprednate | 13 | $1,145 |
| Atropine Sulfate | 15 | $993 |
| Brimonidine Tartrate | 50 | $931 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 68 | $924 |
| Ciprofloxacin Hcl | 56 | $638 |
| Latanoprost | 33 | $413 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $283 |
| Timolol Maleate | 28 | $259 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Saint Louis
- Ranjan MalhotraSaint Louis$809K
- Gregg BerdySaint Louis$360K
- Rajendra ApteSaint Louis$112K
- Ian PithaSaint Louis$85K
- Senthil KrishnasamySaint Louis$46K
- Navin TekwaniSaint Louis$34K
- Steven LeeSaint Louis$33K
- John GalanisSaint Louis$20K
- Bruce CohenSaint Louis$11K
- Sean EdelsteinSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.